Last €74.94 EUR
Change Today +0.033 / 0.04%
Volume 0.0
ABG On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 3:18 PM 12/23/14 All times are local (Market data is delayed by at least 15 minutes).

amerisourcebergen corp (ABG) Snapshot

Open
€74.45
Previous Close
€74.90
Day High
€75.19
Day Low
€74.36
52 Week High
12/8/14 - €75.30
52 Week Low
04/28/14 - €45.05
Market Cap
16.4B
Average Volume 10 Days
9.4
EPS TTM
--
Shares Outstanding
218.7M
EX-Date
11/13/14
P/E TM
--
Dividend
€1.14
Dividend Yield
1.00%
Current Stock Chart for AMERISOURCEBERGEN CORP (ABG)

amerisourcebergen corp (ABG) Details

AmerisourceBergen Corporation sources and distributes pharmaceutical products to healthcare providers, pharmaceutical and biotech manufacturers, and specialty drug patients in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; scalable automated pharmacy dispensing equipment; medication and supply dispensing cabinets; and packaging solutions to institutional and retail healthcare providers. In addition, this segment provides pharmaceutical distribution and other services primarily to physician practices in various disease states, such as oncology, as well as to other healthcare providers, including dialysis clinics; distributes plasma and other blood products, injectible pharmaceuticals, and vaccines; and third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers. The company’s Other segment provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and co-pay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers; and specialty transportation and logistics services for the biopharmaceutical industry. AmerisourceBergen Corporation markets its products and services through independent sales forces and marketing organizations. The company was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.

13,000 Employees
Last Reported Date: 11/25/14
Founded in 1985

amerisourcebergen corp (ABG) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $1.2M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $500.0K
Executive Vice President and President of Ame...
Total Annual Compensation: $600.0K
Executive Vice President and President of Ame...
Total Annual Compensation: $400.0K
Executive Vice President and General Counsel
Total Annual Compensation: $462.0K
Compensation as of Fiscal Year 2013.

amerisourcebergen corp (ABG) Key Developments

AmerisourceBergen Corporation(NYSE:ABC) dropped from S&P 500 Value Index

AmerisourceBergen Corporation(NYSE:ABC) dropped from S&P 500 Value Index

AmerisourceBergen Corporation Announces Executive Changes

On December 5, 2014, the Board of Directors of AmerisourceBergen Corporation promoted Lazarus Krikorian, to Senior Vice President and Corporate Controller and appointed him to serve as principal accounting officer of the company. Tim G. Guttman will continue to serve as the principal financial officer in his role as Executive Vice President and Chief Financial Officer of the company. Mr. Krikorian joined the company in 2002 as the Assistant Corporate Controller. He was named Vice President and Corporate Controller of the company in 2012.

AmerisourceBergen Corporation Announces Increased Quarterly Dividend, Payable on December 1, 2014

AmerisourceBergen Corporation increased the company's quarterly dividend rate 23% to $0.29 per common share from $0.235 per common share. The quarterly dividend of $0.29 per common share will be payable December 1, 2014, to stockholders of record at the close of business on November 17, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABG:GR €74.94 EUR +0.033

ABG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Baxter International Inc $74.45 USD -0.04
Henry Schein Inc $137.87 USD +0.15
IDEXX Laboratories Inc $148.68 USD +1.45
Owens & Minor Inc $35.31 USD +0.01
Tractor Supply Co $77.80 USD -0.66
View Industry Companies
 

Industry Analysis

ABG

Industry Average

Valuation ABG Industry Range
Price/Earnings 76.2x
Price/Sales 0.2x
Price/Book 10.4x
Price/Cash Flow 43.5x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMERISOURCEBERGEN CORP, please visit www.amerisourcebergen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.